Imoisili Omoye E, Sumner Anne E
Curr Cardiovasc Risk Rep. 2009 Jan 1;3(3):161-167. doi: 10.1007/s12170-009-0026-7.
Obesity, hypertension, atherosclerosis, and type 2 diabetes mellitus are increasing in all regions of sub-Saharan Africa. The metabolic syndrome is a valuable tool in predicting atherosclerosis and type 2 diabetes in populations in Europe and North America. However, the applicability of the metabolic syndrome to African populations has not been studied. Prior to investing scarce funds into diagnosing and treating the metabolic syndrome, primary research needs to be designed to determine the prevalence of the metabolic syndrome and its ability to detect early, treatable disease in Africa. Assessment of these data should make it possible to determine if it is more effective to focus on the metabolic syndrome as a whole or on obesity, hypertension, atherosclerosis, and type 2 diabetes as individual conditions. This article is an overview of the presentation of metabolic syndrome variables in the Eastern, Western, and Southern regions of sub-Saharan Africa.
肥胖、高血压、动脉粥样硬化和2型糖尿病在撒哈拉以南非洲的所有地区都呈上升趋势。代谢综合征是预测欧洲和北美人群动脉粥样硬化和2型糖尿病的一个重要工具。然而，代谢综合征在非洲人群中的适用性尚未得到研究。在将稀缺资金投入到代谢综合征的诊断和治疗之前，需要开展基础研究来确定代谢综合征在非洲的患病率及其检测早期可治疗疾病的能力。对这些数据的评估应能确定将重点放在整个代谢综合征上还是放在肥胖、高血压、动脉粥样硬化和2型糖尿病这些个体病症上更为有效。本文概述了撒哈拉以南非洲东部、西部和南部地区代谢综合征变量的情况。
